Molecular docking revealed strong binding interactions between KANK2 and these compounds, involving different mechanisms such as cell cycle control, DNA synthesis, and signaling pathways that inhibit tumor cell growth and proliferation46-48. This evidence concerns the gene KANK2 and neoplasm.